The global inhalation therapy nebulizer market size was valued at USD 620 million in 2019 and it is expected to reach USD 1010 million by 2026, expanding at a CAGR of 7.6%, according to a new report by Facts & Factors.

Click here to read the complete article: https://www.fnfresearch.com/inhalation-therapy-nebulizer-market-by-product-pneumatic-nebulizers-1292

Market Synopsis:

Inhalation therapies are a collection of pulmonary or lung therapists, which are procedures intended to either regain or enhance a patient’s capacity for breathing. These procedures are used on patients suffering from a variety of illnesses, disorders, or accidents. Treatment via inhalation A nebulizer is a piece of medical equipment that is utilized in the process of administering necessary medication via inhalation therapy. When a large dose of a drug that is administered via inhalation is required, it is simple. In addition to this, it is utilized in a wide variety of medical treatments and medications, including those designed to treat the symptoms of asthma and provide instant relief. When compared to MDIs, the nebulizer can be simpler to operate, particularly for young children, infants, and anyone else who has difficulty using an asthma inhaler. Nebulizers are also more convenient for those who need to take multiple puffs of medication. Using a nebulizer decreases the likelihood of experiencing the adverse effects that are normally connected with taking high doses of prescribed medications. The nebulizer is available for use in the treatment of a variety of respiratory and illness conditions, including asthma, cystic fibrosis, bronchitis, COPD, and the common cold. There are a few distinct varieties of nebulizers available on the market today, the most common of which is the ultrasonic wave nebulizer, the pneumatic nebulizer, and the mesh nebulizer.

Market Drivers:

The increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and other obstructive lung diseases across the world is hastening the expansion of the market for nebulizers used in inhalation therapy. The World Health Organization estimates that 235 million people around the world suffer from asthma. One of the most common types of persistent respiratory illness is asthma. According to projections made by the WHO, COPD will move up to the third spot on the list of leading causes of death worldwide by the year 2030. Nebulizers are frequently used in the treatment of respiratory conditions due to the benefits that they offer, such as ease of use in comparison to the dried powder that is contained within an inhaler.

In addition, air pollution all over the world and an ageing population plagued by multiple diseases are both contributing factors that are helping to drive growth in the demand for nebulizer inhalation therapy. On the other hand, the possibility of drug loss caused by the nebulizer during the delivery of the medication into the mist is one of the major issues that could hinder the growth of the demand for nebulizer inhalation therapy. This is one of the major issues that could hinder the growth of the demand for nebulizer inhalation therapy. In addition, it is anticipated that the utilisation of nebulizer inhalation therapy in the treatment of other diseases, such as diabetes and migraine, will open up new doorways for the expansion of opportunities in the market for nebulizer inhalation therapy.

Segmental Overview:

The global market for inhalation therapy nebulizers is divided into three distinct segments: product, application, and region. Pneumatic Nebulizers, Ultrasonic Nebulizers, and Mesh Nebulizers are the three sub-categories that make up this product segment. The application market is subdivided into categories such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, nasal congestion, asthma, and others.

Key Players:

Top key players operating in the market 3M, AptarGroup, Inc., Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., OMRON Corporation, DeVilbiss Healthcare LLC, PARI GmbH Spezialisten für effektive Inhalation, Air Liquide Medical Systems, A&D Company, GF HEALTH PRODUCTS, INC., Vyaire Medical Inc., and Trudell Medical International amongst others.

Regional Overview:

In terms of geography, North America was responsible for the largest portion of the total global demand for nebulizer inhalation therapy throughout the region. Nebulizers for inhalation therapy are in higher demand in the United States as a result of the high prevalence of COPD and asthma among adults and children. Consumer demand in the North American region is driven in part by a number of factors, including well-developed healthcare infrastructures and technological advancements. In the foreseeable future, there is anticipated to be a sizeable increase in the number of people in Europe looking for nebulizers used in inhalation therapy. Increasing awareness of the use of nebulizers and favourable health policies are some factors that will drive demand for the inhalation therapy nebulizer market in the Europe region during the forecast period.

This report segments the Inhalation Therapy Nebulizermarket as follows:

Global Inhalation Therapy Nebulizers Market: Product Type Segment Analysis

  • Pneumatic Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

Global Inhalation Therapy Nebulizers Market: Application Segment Analysis

  • COPD
  • Cystic Fibrosis
  • Nasal Congestion
  • Asthma
  • Others

Global Inhalation Therapy NebulizerMarket: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors

A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com

Read More:

[Latest] Global 5G Wireless Ecosystem Market Size Worth USD 3,88,835 Mn by 2027 at a 24.5% CAGR: Report by Facts Factors

Chris Arnold on LinkedIn: #catheter #stabilization #device #market #marketanalysis #marketsize…

Chris Arnold on LinkedIn: #cardiaccare #healthcare #medical #equipments #marketanalysis #marketsize…

Global Fabry Disease Treatment Market Size, Share, Trends, Opportunities Analysis, and Forecast Report by 2026 – FNF News Blog

Global Fabry Disease Treatment Market Industry Analysis and Forecast 2022-2028 – by Type, Application, and Region

Global Aerospace & Defense Elastomers Market Size, Share & Trends Analysis Report 2022-2028

Global Air Refueling Market Industry Share, Growth, Trends Analysis Report 2028

Global Biliary Stents Market Analysis, Size, Share, Growth, Trends and Forecast 2022-2028

Global Fabricated Metals Market Trends, Growth Rate, Opportunities & Forecast To 2028